Sequential Activation of Vulnerable Plaques Endorsing the Inflammatory Hypothesis of Atherosclerosis by Manolis, Antonis S et al.
69 
 
 
IMAGES IN CARDIOLOGY   
Sequential Activation of Vulnerable Plaques Endorsing 
the Inflammatory Hypothesis of Atherosclerosis  
Antonis S. Manolis, MD, Pantelis Toskas, MD, 
Konstantinos Aznaouridis, MD  
Athens University School of Medicine, Ippokrateio 
Hospital, Athens, Greece  
Abstract 
A case of sequential activation of vulnerable plaques in two 
different coronary vessels over the course of 2 days is being 
presented probably related to inflammation inciting these acute 
coronary events. Rhythmos 2017;12(4): 69-70.   
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A 66-year-old gentleman was referred for coronary 
angiography due to recent crescendo angina and a positive 
exercise tolerance test. He complained of anginal 
symptoms over the past one year but symptomatology 
worsened dramatically over the past few weeks. Two 
weeks earlier he underwent an exercise test which was 
positive for symptomatic inferolateral ischemia (Fig. 1). 
Coronary risk factors included smoking, diabetes mellitus 
managed with oral hypoglycemic agents and hyperchole-
sterolemia treated with atorvastatin. Coronary angio-
graphy revealed a critical lesion at the proximal segment 
of the left circumflex (Fig. 2, panel A, arrow), disease at 
the proximal and mid segment of the obtuse marginal 
branch and borderline lesions of the left anterior 
descending (LAD) (Fig. 2, panels B/D, arrows) after a 
large ramus intermedians (RI) branch. Percutaneous 
coronary intervention (PCI) with direct stenting of the left 
circumflex was performed successfully during the same 
session. Result is seen in Fig. 2, panel C, arrow).  
 Figure 1. Depression of the ST segment was noted at peak 
exercise in leads II, III, aVF and V6 indicative of inferolateral 
wall ischemia.  
 Figure 2. Right anterior oblique (RAO) views are displayed in 
panels A, C and D and a left anterior oblique view in panel B. 
See text for discussion.   
One day after hospital discharge, the patient developed 
two episodes of rest angina, with clinical characteristics 
differing from the initial ones in terms of precordial chest 
pain location and nature. He sought medical attention and 
was re-admitted after the second episode. Upon admission, 
new ST-T changes were recorded with biphasic T waves 
in leads V2-4 (Fig. 3) and mild elevation of cardiac 
troponin T. A repeat coronary angiogram was obtained 
showing a patent stent of the left circumflex (Fig. 4, panel 
A, arrowhead) with critical stenosis of the LAD lesion 
(Fig. 4, panel A, arrow). After coronary injection of 300 
μg of nitroglycerin, the lesion was partially improved, 
while a second lesion became apparent distal to the first 
one (Fig. 4, panels B/C/D, arrows); both lesions were 
distinctly hazy. Due to close vicinity of the first proximal 
lesion with the large RI branch and risk of possible 
compromise of this branch should a PCI be performed, 
initial dilation of the second lesion was decided. After 
direct stenting of the lesion and additional intracoronary 
injection of nitroglycerin, more angled views of the LAD 
were taken and analyzed, with some of them showing 
borderline degree of stenosis, and one (right anterior 
oblique with caudal angulation) indicating a significant 
(~80%) stenosis. Due to patient’s presenting symptoms of 
acute coronary syndrome and ECG changes pointing to the 
LAD as the culprit vessel, it was finally decided to proceed 
with further proximal stenting and thus complete 
revascularization of the LAD lesions. There were thoughts 
of using intravascular ultrasound to guide placement of the 
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proximal LAD stent to avoid compromise of the RI branch. 
However, in order to keep it simple, direct stenting was 
cautiously undertaken and successfully performed without 
running into problems by landing the proximal end of the 
stent precisely in juxta-position to the RI origin. Final 
result is displayed in Figure 4, panels E and F (arrows).  
 Figure 3. Biphasic T waves were noted in leads V2-4 and 
negative T waves in lead aVL, suggestive of ischemia at a 
distance from the initially stented vessel (left circumflex) going 
along with the new angiographic findings of critical disease in 
the left anterior descending (LAD) coronary artery (see Fig. 4).   
 Figure 4. LAO views are displayed in panels A and B, and RAO 
views in panels C, D, E and F. See text for discussion.   
Patient’s post-procedural course was uneventful and he 
was discharged home in two days and has been 
asymptomatic for the ensuing three weeks.  
●●● 
Although the exact inciting factors of the vulnerable 
plaque rupture are unknown, inflammation is considered to 
play a pivotal role in such an event. Indeed, acute coronary 
syndromes (ACS) have long been considered to be 
triggered by a generalized inflammatory process for which 
limited management options have been available. 
Concurrent activation of multiple lesions has been reported 
in up to one third of patients with ACS. 1-5 Although we 
did not use intravascular imaging techniques (ultrasound 
or optical coherence tomography) to identify vulnerable 
plaques in our patient and/or C-reactive protein levels to 
determine an inflammatory process activation,6 the 
clinical, ECG, and angiographic features were consistent 
with such a scenario. Coronary vasospasm might have also 
played a role, however, the lesions of the LAD had worse 
angiographic appearance compared to their prior depiction 
even after reversal of the vasospastic component after the 
intracoronary injection of nitroglycerin.  
Multiple plaque rupture has been associated with 
systemic inflammation, and a poor prognosis.2 Fortuna-
tely, our patient did not sustain any life-threatening 
complications of recurring ischemia due to activation of 
coronary plaques at a second vessel and was fortunate to 
make it back to the hospital and undergo successful PCI. 
Preliminary studies have emerged that show that anti-
inflammatory therapies may benefit patients with ACS. 7 
However, until these data are corroborated by further 
studies and suggested therapies become more practical, our 
current anti-inflammatory approach is practically limited 
to use of high-intensity statin therapy to avail of the 
pleiotropic and plaque-stabilizing effects of such therapy,8-
10 combined with potent antiplatelet treatment and 
aggressive risk factor modifying strategies.11   
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